Xtacy Therapeutics (TSE:XTCY) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Xtacy Therapeutics Corp. has announced that it will strengthen its financial position by issuing 3,580,500 common shares to settle CA$179,025 of debt owed to various creditors. The shares, priced at $0.05 each, will be subject to a four-month statutory hold period following issuance. This strategic move is aimed at reducing the company’s liabilities and improving its financial stability.
For further insights into TSE:XTCY stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue